Essity has today raised EUR 600m in the bond market under its Euro Medium Term Note (EMTN) program. The re-offer yield for the bond was 0.33% with a maturity date of September 15, 2029, corresponding to mid swaps +0.43 percentage points.
Hygiene and health company Essity has finalized its acquisition of 45.8% of the shares in Colombian hygiene company Productos Familia S.A. (“Familia”). Essity now owns 95.8% of Familia. The purchase price amounts to USD 1,540m (approximately SEK 13bn) for 100% of the company on a debt free basis. The acquisition is expected to be accretive to Essity’s earnings per share from 2021.
According to Essity’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company. When such a conversion has occurred, the company is obligated by law to disclose any such changes in this manner.
Welcome to Essity’s virtual Capital Markets Day for investors, analysts and the media on November 3, 2021, at 2:00 p.m.-5:00 p.m. CET.
Hygiene and health company Essity today presents new and updated sustainability targets including a commitment to develop targets to reach net-zero greenhouse gas emissions by 2050 at the latest. This includes raising the ambition level of Essity’s current Science Based Targets. Other updated targets include sustainable innovations, occupational safety and responsible sourcing.
Hygiene and health company Essity expands its partnership with United Nations (UN) Foundation by joining a cross-industry group that brings together corporate experts in the fight against antimicrobial resistance (AMR). Essity is a global provider of hand hygiene and wound care solutions, essentials in the fight against antimicrobial resistance, one of the greatest global public health threats predicted to be responsible for 10 million annual deaths worldwide by 2050. Essity has been a partner to the United Nations Foundation since 2017.
Global hygiene and health company Essity invests approximately EUR 11m (approximately SEK 110m) in its Hondouville mill in France, allowing to extract 98% of paper fibers contained in food and beverage cartons.
The process following the acquisition of the remaining 25% of the shares of ABIGO Medical AB is completed and the company is now a wholly owned subsidiary of Essity. As per the terms of the transaction, ABIGO Medicals pharma business has been divested and sold to the company’s founder Jan G. Smith.
Hygiene and health company Essity has today finalized its acquisition of the remaining 63.8% of the shares in the Australian hygiene company Asaleo Care. Essity AustralAsia, which is the name of the regional unit going forward, will be consolidated into Essity’s accounts as of July 1[st ], 2021.